Blood Transfusion Diagnostics Market Share

Statistics for the 2023 & 2024 Blood Transfusion Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Blood Transfusion Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Blood Transfusion Diagnostics Industry

The Blood Transfusion Diagnostics Market is consolidated in nature. The competitive landscape includes an analysis of a few international and local companies that hold market shares and are well known. The key players in the market include Grifols, S.A., F. Hoffmann-La Roche Ltd., Immucor, Inc., Bio-Rad Laboratories, Inc., Quotient Suisse SA, Merck KGaA, Abbott, Diasorin S.p.A, Danaher, and Werfen among others.

Blood Transfusion Diagnostics Market Leaders

  1. Grifols, S.A.

  2. F. Hoffmann-La Roche Ltd.

  3. Diasorin S.p.A

  4. Bio-Rad Laboratories, Inc.

  5. Quotient Suisse SA

*Disclaimer: Major Players sorted in no particular order

Blood Transfusion Diagnostics Market Concentration

Blood Transfusion Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)